Melatonin prevents neonatal dexamethasone induced programmed hypertension: Histone deacetylase inhibition

Journal of Steroid Biochemistry and Molecular Biology

Volumn 144, Issue PART B, 2014, Pages 253-259

  Wu, Ting Hsin ^a   Kuo, Hsuan Chang ^a   Lin, I Chun ^a   Chien, Shao Ju ^a   Huang, Li Tung ^a   Tain, You Lin ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Asymmetric dimethylarginine; Histone deacetylase; Hypertension; Melatonin; Oxidative stress; Renin angiotensin system

Indexed keywords

6 N,N' DIMETHYLARGININE; ARGININE; CITRULLINE; DEXAMETHASONE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE H3; HISTONE H4; MELATONIN; N(G),N(G) DIMETHYLARGININE; TRICHOSTATIN A; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DRINKING WATER; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; PROTEIN; SODIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; SODIUM PROTON EXCHANGE PROTEIN 3; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERTENSION; MALE; NONHUMAN; ONCOGENE RAS; OXIDATIVE STRESS; PROGRAMMED HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM TRANSPORT; TREATMENT DURATION; AGE; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; EXPERIMENTAL HYPERTENSION; KIDNEY DEVELOPMENT; LACTATION; NEWBORN; PERINATAL DRUG EXPOSURE; PROGENY; PUP (RODENT); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT RESPONSE; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; BLOOD PRESSURE; BODY WEIGHT; DEXAMETHASONE; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; HYPERTENSION; KIDNEY; MALE; MELATONIN; ORGAN SIZE; OXIDATIVE STRESS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM;

EID: 84906830077     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.07.008     Document Type: Article

References (30)

1. N.B. Ojeda, D. Grigore, and B.T. Alexander Developmental programming of hypertension: insight from animal models of nutritional manipulation Hypertension 52 2008 44 50
2. F.A. Scheer Potential use of melatonin as adjunct antihypertensive therapy Am. J. Hypertens. 18 2005 1619 1620 (Pubitemid 41814685)
3. R.J. Reiter, D.X. Tan, and A. Korkmaz The circadian melatonin rhythm and its modulation: possible impact on hypertension J. Hypertens. 27 2009 S17 S20
4. A. Galano, D.X. Tan, and R.J. Reiter On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK J. Pineal. Res. 54 2013 245 257
5. Y.L. Tain, L.T. Huang, I.C. Lin, Y.T. Lau, and C.Y. Lin Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats J. Pineal. Res. 49 2010 390 398
6. L.A. Ortiz, A. Quan, F. Zarzar, A. Weinberg, and M. Baum Prenatal dexamethasone programs hypertension and renal injury in the rat Hypertension 41 2003 328 334 (Pubitemid 36204910)
7. W.B. de Vries, F.R. van der Leij, J.M. Bakker, P.J. Kamphuis, M.F. van Oosterhout, and M.E. Schipper et al. Alterations in adult rat heart after neonatal dexamethasone therapy Pediatr. Res. 52 2002 900 906 (Pubitemid 35379471)
8. W.B. de Vries, P. van den Borne, R. Goldschmeding, R.A. de Weger, M.P. Bal, and F. van Bel et al. Neonatal dexamethasone treatment in the rat leads to kidney damage in adulthood Pediatr. Res. 67 2010 72 76
9. Committee on Fetus and Newborn Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants Pediatrics 109 2002 330 338
10. A.R. Stark, W.A. Carlo, J.E. Tyson, L.A. Papile, L.L. Wright, and S. Shankaran et al. Adverse effects of early dexamethasone in extremely-low-birth- weight infants. National Institute of Child Health and Human Development Neonatal Research Network N. Engl. J. Med. 344 2001 95 101
11. H.L. Halliday, R.A. Ehrenkranz, and L.W. Doyle Early (<8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants Cochrane Database Syst. Rev. 1 2009 CD001146
12. M.P. Bal, W.B. de Vries, P. Steendijk, P. Homoet-van der Kraak, F.R. van der Leij, and J. Baan et al. Histopathological changes of the heart after neonatal dexamethasone treatment: studies in 4-, 8-, and 50-week-old rats Pediatr. Res. 66 2009 74 79
13. P.J. Kamphuis, W.B. de Vries, J.M. Bakker, A. Kavelaars, J.E. van Dijk, and M.E. Schipper et al. Reduced life expectancy in rats after neonatal dexamethasone treatment Pediatr. Res. 61 2007 72 76 (Pubitemid 46352319)
14. N. Sengupta, and E. Seto Regulation of histone deacetylase activities J. Cell. Biochem. 93 2004 57 67
15. S. Chen, C. Bellew, X. Yao, J. Stefkova, S. Dipp, and Z. Saifudeen et al. Histone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation J. Biol. Chem. 286 2011 32775 32789
16. R. Song, T. Van Buren, and I.V. Yosypiv Histone deacetylases are critical regulators of the renin-angiotensin system during ureteric bud branching morphogenesis Pediatr. Res. 67 2010 573 578
17. V. Vallon, and F. Lang New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure Curr. Opin. Nephrol. Hypertens. 14 2005 59 66 (Pubitemid 40110701)
18. R. Sharma, T. Ottenhof, P.A. Rzeczkowska, and L.P. Niles Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells J. Pineal. Res. 45 2008 277 284
19. A. Korkmaz, S. Rosales-Corral, and R.J. Reiter Gene regulation by melatonin linked to epigenetic phenomena Gene 503 2012 1 11
20. B. Jung-Hynes, R.J. Reiter, and N. Ahmad Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer J. Pineal. Res. 48 2010 9 19
21. Y.L. Tain, C.C. Chen, J.M. Sheen, H.R. Yu, M.M. Tiao, and H.C. Kuo et al. Melatonin attenuates prenatal dexamethasone-induced blood pressure increase in a rat model J. Am. Soc. Hypertens. 8 2014 216 226
22. Y.L. Tain, J.M. Sheen, C.C. Chen, H.R. Yu, M.M. Tiao, and H.C. Kuo et al. Maternal citrulline supplementation prevents prenatal dexamethasone-induced programmed hypertension Free Radic. Res. 48 2014 580 586
23. H. Noh, E.Y. Oh, J.Y. Seo, M.R. Yu, Y.O. Kim, and H. Ha et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury Am. J. Physiol. Renal. Physiol. 297 2009 F729 F739
24. Y.L. Tain, W.C. Lee, C.N. Hsu, W.C. Lee, L.T. Huang, and C.T. Lee et al. Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers PLoS One 8 2013 e55420
25. S. Racasan, B. Braam, H.A. Koomans, and J.A. Joles Programming blood pressure in adult SHR by shifting perinatal balance of NO and reactive oxygen species toward NO: the inverted Barker phenomenon Am. J. Physiol. Renal. Physiol. 288 2005 F626 F636
26. Y. Feng, H. Xia, R.A. Santos, R. Speth, and E. Lazartigues Angiotensin-converting enzyme 2: a new target for neurogenic hypertension Exp. Physiol. 95 2010 601 606
27. K. Struhl Histone acetylation and transcriptional regulatory mechanisms Genes Dev. 12 1998 599 606 (Pubitemid 28134293)
28. Y.L. Tain, L.T. Huang, C.N. Hsu, and C.T. Lee Melatonin therapy prevents programmed hypertension and nitric oxide deficiency in offspring exposed to maternal caloric restriction Oxid. Med. Cell. Longev. 2014 2014 283180
29. M. Dodic, K. Moritz, I. Koukoulas, and E.M. Wintour Programmed hypertension: kidney, brain or both? Trends Endocrinol. Metab. 13 2002 403 408 (Pubitemid 36723594)
30. R. Winkler, V. Benz, M. Clemenz, M. Bloch, A. Foryst-Ludwig, and S. Wardat et al. Histone deacetylase 6 (HDAC6) is an essential modifier of glucocorticoid-induced hepatic gluconeogenesis Diabetes 61 2012 513 523